Disappointment for Moberg in Phase II onychomycosis trial
10 February 2012
Pial Ganguli
Please Login to read the full article.
10 February 2012
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- AstraZeneca to take $381.5 million charge after two major trial failures
- Valeant aspires to #1 in derma as it adds J&J's Ortho unit for $345 million
- Novartis buys Fougera for $1.5 billion cash to boost Sandoz dermatology business
- AstraZeneca dumps Targacept's antidepressant TC-5214 after two more Ph III failures
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
